Latest Greenlight Capital Re (GLRE) Headlines Global

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Latest Greenlight Capital Re (GLRE) Headlines

Global Indemnity (GBLI) Surges: Why It Still Has Room to Run? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Mar 10, 7:39AM CDT
Global Indemnity has been witnessing a significant price rise in the past month with a positive momentum in the earnings estimate front

Greenlight Capital Re Earnings Hindsight: Down 1.4% in Last 20 Days (GLRE)
Comtex SmarTrend(R) - Mon Mar 10, 7:37AM CDT
Two weeks ago on February 18th, 2014 Greenlight Capital Re (NASDAQ:GLRE) reported earnings and analysts, on average, expected earnings of $2.42 on sales of $221.0 million. Greenlight Capital Re actually reported earnings of $2.22 per share on sales of $224.0 million, missing EPS estimates by $0.20 and beating revenue estimates by $3.0 million. Shares of Greenlight Capital Re have slipped from $32.37 to $31.93, representing a loss of 1.4%, since the company reported earnings 20 days ago.

Infinity Property and Casualty Earnings Miss Ests, Up Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 11:40AM CST
Infinity Property and Casualty reported fourth-quarter 2013 operating earnings of 70 cents a share, missing the Zacks Consensus Estimate of 75 cents by 6.7%.

Global Indemnity (GBLI) in Focus: Stock Moves 8.1% Higher - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 24, 8:21AM CST
Global Indemnity plc (GBLI) was a big mover last session, as the company saw its shares rise by over 8% on the day.

RenaissanceRe Hikes Quarterly Dividend - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 3:00PM CST
The board of directors of RenaissanceRe approved a 3.6% increase in its quarterly cash dividend and the company will now pay a dividend of 29 cents per share.

EMC Insurance Beats on Q4 Earnings, Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 21, 11:50AM CST
EMC Insurance reported fourth-quarter operating net earnings of 95 cents a share, surpassing the Zacks Consensus Estimate of 87 cents a share by 9.2%

Maiden Beats on Q4 Earnings, Misses Revs - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 12:00PM CST
Maiden Holdings reported record fourth-quarter 2013 operating net earnings of 30 cents a share, beating the Zacks Consensus Estimate of 28 cents by 7.1%.

Greenlight Misses on Q4 Earnings, Grows Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 20, 10:00AM CST
Greenlight Capital Re, Ltd. reported fourth-quarter 2013 net earnings per share of $2.22

Greenlight Re Announces Fourth Quarter and Year End 2013 Financial Results
GlobeNewswire - Tue Feb 18, 3:01PM CST
Greenlight Capital Re, Ltd. (Nasdaq:GLRE) today announced financial results for the fourth quarter and year ended December 31, 2013. Greenlight Re reported net income of $83.9 million for the fourth quarter 2013 compared to net loss of $60.6 million for the same period in 2012. Fully diluted net income per share was $2.22 compared to net loss per share of $1.65 for the same period in 2012.

Cincinnati Financial Slips to Neutral - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 5:55PM CST
We are downgrading our recommendation on Cincinnati Financial to Neutral from Outperform, reflecting our concern regarding potential first-quarter earnings drain due to weather-related losses.

Greenlight Capital Re to Release Fourth Quarter and Year End 2013 Results
GlobeNewswire - Tue Feb 11, 3:01PM CST
Greenlight Capital Re, Ltd. (Nasdaq:GLRE), a specialist property and casualty reinsurer based in the Cayman Islands and Ireland, today announced that it expects to release financial results for the fourth quarter and year ended December 31, 2013 after the market closes on Tuesday, February 18, 2014. A live conference call to discuss the financial results will be held on Wednesday, February 19, 2014 at 9:00 a.m. Eastern time.

Markel's Earnings Miss, Revs Top Ests - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 11, 10:20AM CST
Markel reported fourth-quarter 2013 operating net income of $5.92 per share, missing the Zacks Consensus Estimate of $5.99 per share by 1.2%

Q4 Earnings at Allied World Miss Ests, Surge Y/Y - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 10:40AM CST
Allied World reported fourth-quarter 2013 operating net income of $2.17 per share, missing the Zacks Consensus Estimate of $2.40 by 10.4%

Shares of GLRE Up 37.9% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jan 23, 4:56PM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 12 months, Greenlight Capital Re has returned 37.85% as of today's recent price of $33.03.

Greenlight Capital Re Has Returned 40.2% Since SmarTrend Recommendation (GLRE)
Comtex SmarTrend(R) - Thu Jan 16, 11:08AM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 12 months, Greenlight Capital Re has returned 40.23% as of today's recent price of $33.60.

Insurance Industry Stock Outlook - Jan 2014 - Industry Outlook
Kalyan Nandy - Zacks Investment Research - Tue Jan 14, 4:06AM CST
Insurance Industry Stock Outlook - Jan 2014 - Industry Outlook

Insurance Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews
Kalyan Nandy - Zacks Investment Research - Tue Jan 14, 4:06AM CST
Insurance Industry Stock Outlook - Jan 2014 - Zacks Analyst Interviews

Greenlight Capital (GLRE): Strong Industry, Solid Earnings Estimate Revisions - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jan 13, 7:34AM CST
Greenlight Capital belongs to the Property and Casualty Insurance industry space witnessed solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective.

Greenlight Capital Re Shares Up 39.9% Since SmarTrend's Buy Recommendation (GLRE)
Comtex SmarTrend(R) - Thu Jan 09, 9:47AM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 11 months, Greenlight Capital Re has returned 39.86% as of today's recent price of $33.51.

Greenlight Capital Re Up 39.9% Since SmarTrend Uptrend Call (GLRE)
Comtex SmarTrend(R) - Thu Jan 02, 9:17AM CST
SmarTrend identified an Uptrend for Greenlight Capital Re (NASDAQ:GLRE) on January 31st, 2013 at $23.96. In approximately 11 months, Greenlight Capital Re has returned 39.86% as of today's recent price of $33.51.

Greenlight Capital Re Ltd. (GLRE) Stock Research Links

GLRE Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

CrossCountry Mortgage Boosts Loan Limits, Flexibility for 2027

Updated Category News Views 27

Trailblazing in the Mortgage Game Well, what do we have here? CrossCountry Mortgage, the big cheese of retail mortgage lenders, is cranking up their conforming loan limits to a hefty $845,000. They're jumping the gun on the Federal Housing Finance Agency's official 2027 announcement. It's a classic move—proactive, bold, and a bit of a gamble, if you ask me. They’re...

Continue Reading
Jari Spirits Set to Shake Up U.S. Market After Big Wins

Updated Category News Views 1

Korean Spirits Jari Eyes U.S. Market Entry Some stories just have that perfect 'right time, right place' vibe, and CJ Foods' recent splash with their Korean spirits brand jari is one of them. Buckle up, because this one's about a Korean distilling sensation gearing up to hit American shores with a bang. Accolades Pave the Path Jari, the premium Korean distilled spirits...

Continue Reading
Oil Markets Shift Focus: Pipelines Trump Drilling

Updated Category News Views 3

Decoupling Oil Price and Production Response This oil market isn’t your usual rodeo. With Brent flirting with $100, it’s a seismic shift that’s not yielding new drills but redirecting capital to the existing infrastructure landscape. Ask yourself why we're not seeing the usual cavalry charge of new rigs. It’s simple: Pipeline mileage and producing wells have...

Continue Reading
Havoc, CSBC Partner for Autonomous Maritime Future

Updated Category News Views 7

A Strategic Move Across the Pacific Well, folks, in an era where the seas aren't just blue but powered by tech-backed autonomy, here's a new chapter—the kind that doesn't just hint at innovation, it screams it. Havoc, that crafty leader in all things autonomous, inked a game-changing deal with Taiwan's shipbuilding behemoth, CSBC Corporation. They're not just building...

Continue Reading
Flex Dental Solutions Adds BNPL, Surcharging to FlexPayments

Updated Category News Views 7

Diving into Dental Finances: A New Moneymaker? It's about time someone shook up the dental payment scene, and Flex Dental Solutions seems to be the one doing it. They rolled out some intriguing new features for their FlexPayments platform aimed squarely at dental practices using Open Dental. What we're seeing here is their attempt to bridge a couple of financial headaches...

Continue Reading
Fermi's Founder Pushes for Board Overhaul: What's Next?

Updated Category News Views 2

Fermi's Roller Coaster: A Founder’s Stand Seems like Fermi Inc. is on a wild ride through the business landscape, and it's giving shareholders more whiplash than satisfaction these days. Toby Neugebauer, co-founder of Fermi and the loudest voice in the room, is feeling like his company is facing some serious turbulence and seems determined not to sit idly by as it hits...

Continue Reading
Modeling and Mental Health Join Forces for Wellness

Updated Category News Views 2

A Fresh Alliance for Mental Wellness in Modeling Alright, let's shine a spotlight on a significant step in the modeling industry, a place typically less vocal about mental health. In a move that feels long overdue, Brain-Body Therapy and Mother Model Management have joined forces, marking the beginning of a collaborative effort to propel mental wellness to the forefront...

Continue Reading
Intus Bio Secures $2.7M for Colorectal Cancer Test

Updated Category News Views 4

Pioneering Efforts in Early-Onset Colorectal Cancer Detection The battlefield of colorectal cancer prevention just got a serious upgrade with Intus Bio grabbing a $2.7 million award. This ain't just pocket change—it's a shot at rewriting the script on how we approach early-onset colorectal cancer, the pesky number one cancer gnawing at the under-50 crowd. Partnering...

Continue Reading
Veteran Marketer Joins The Wisory's Advisory Board

Updated Category News Views 5

Tyrrell Schmidt Joins The Wisory's Board Out of the blue, The Wisory has snatched Tyrrell Schmidt right off the retirement bench. This doesn't seem like just another board seating; it smells like a calculated power play. Schmidt, fresh from her heavyweight stint as Global CMO at TD Bank, adds a spicy dose of marketing prowess to The Wisory's already loaded Advisory Board....

Continue Reading
OneAscent Welcomes Monica Stoudemire as New CCO

Updated Category News Views 5

New Leadership in Compliance Diving straight into the tumultuous sea of securities compliance, OneAscent's got a fresh captain at the helm. Monica Stoudemire's stepped into the Chief Compliance Officer's shoes with a track record that'd make any investor breathe a sigh of relief. After all, blending two decades of on-the-ground experience with regulatory acumen ain't...

Continue Reading
n>

Top 5 Most Recently Viewed Articles

3 Buy-Now-Pay-Later Stocks Set for Holiday Season Gains

Updated Category News Views 74

Exciting Prospects for BNPL Stocks This Holiday Season As we step into the vibrant holiday shopping season, consumers find themselves preparing to splurge on gifts and holiday cheer. With inflationary pressures and high-interest rates shaping spending behavior, many shoppers are seeking alternatives, such as Buy Now Pay Later (BNPL) solutions that cater to their financial...

Continue Reading
Supreme Court Ruling Enhances Corporate Transparency Efforts

Updated Category News Views 141

Supreme Court Ruling Enhances Corporate Transparency Efforts The U.S. Supreme Court has made a significant decision that reinforces the enforcement of federal anti-money laundering regulations. Corporations will now be required to disclose the identities of their true beneficial owners to the U.S. Treasury Department, marking an important shift in corporate governance and...

Continue Reading
Breakthrough Medical Device Addresses Lipohypertrophy in Diabetes

Updated Category News Views 522

Revolutionizing Diabetes Treatment with Embrace Patch Recent clinical trials have shed light on the embrace Active Site Care compression patch, a pioneering medical device that has demonstrated its efficacy in treating lipohypertrophy (LH) in individuals using insulin for diabetes management. This breakthrough reveals how comprehensive care and innovative technology can...

Continue Reading
Sobi Experiences Increase in Shares and Voting Rights

Updated Category News Views 242

Significant Changes in Shares and Votes at Sobi As of the recent announcement, the total number of shares in Swedish Orphan Biovitrum AB (publ) (Sobi) has reached an impressive 357,412,837. This total is made up of 356,000,049 common shares and 1,412,788 C-shares. Notably, the increase of shares and corresponding voting rights is attributed to the recent issuance of...

Continue Reading
Rapid Expansion of the Drug Screening Market Overview

Updated Category News Views 122

Transformation in the Rapid Drug Screening Market The rapid drug screening market is currently experiencing a remarkable transformation, fueled by growing public health concerns, evolving workplace safety regulations, and significant technological advancements. The market, valued at approximately USD 2.4 billion, is expected to expand at a compound annual growth rate...

Continue Reading